Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × tasquinimod × Clear all

NCT02057666 2021-04-23

TasQ003

Phase 3 Terminated

146 enrolled 13 charts

Neoplasm Metastasis, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT00560482 2015-10-26

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT01234311 2015-10-21

A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms